Compare CYRX & BRBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CYRX | BRBI |
|---|---|---|
| Founded | 1999 | 2009 |
| Country | United States | Brazil |
| Employees | 1100 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 421.6M | 394.5M |
| IPO Year | 2008 | N/A |
| Metric | CYRX | BRBI |
|---|---|---|
| Price | $8.05 | $14.04 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $12.94 | N/A |
| AVG Volume (30 Days) | ★ 341.9K | 2.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 5.27% |
| EPS Growth | ★ 156.22 | N/A |
| EPS | ★ 1.40 | N/A |
| Revenue | ★ $176,177,000.00 | N/A |
| Revenue This Year | $9.71 | $39.17 |
| Revenue Next Year | $9.56 | $22.91 |
| P/E Ratio | ★ $4.99 | $11.72 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.63 | $12.54 |
| 52 Week High | $11.45 | $67.01 |
| Indicator | CYRX | BRBI |
|---|---|---|
| Relative Strength Index (RSI) | 37.26 | 46.43 |
| Support Level | $6.57 | $13.82 |
| Resistance Level | $8.45 | $14.65 |
| Average True Range (ATR) | 0.51 | 0.34 |
| MACD | 0.04 | -0.11 |
| Stochastic Oscillator | 25.71 | 12.56 |
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.
BRBI BR Partners SA, formerly BR Advisory Partners Participacoes SA, is engaged in investing in other companies, domestic or foreign, as a partner, quota holder, or shareholder, and management of its assets. It has a single reportable segment being investment banking services, which are administered and managed according to the products offered.